Document:

Exhibit 4.1

 

Forms of Fixed Rate Global Notes

 

Registered

CUSIP No. 40428HTA0

ISIN No. US40428HTA04

 

Principal Amount $[ ]

 

Unless this certificate is presented by an authorized representative
of The Depository Trust Company, a New York corporation (“DTC”), to Issuer or its agent for registration of transfer, exchange
or payment and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by an authorized
representative of DTC (and any payment is made to Cede & Co. or to such other entity as is requested by an authorized representative
of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner
hereof, Cede & Co., has an interest herein.

 

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR THE INDIVIDUAL
DEBT SECURITIES REPRESENTED HEREBY, THIS GLOBAL SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY OR BY A NOMINEE OF
THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR OF THE DEPOSITARY
OR A NOMINEE OF SUCH SUCCESSOR.

 

This Global Security is not a deposit and is not insured by the Federal
Deposit Insurance Corporation or any other governmental agency.

 

HSBC USA INC.

 

GLOBAL SECURITY

 

representing

 

3.750% Senior Notes due May 24, 2024

 

HSBC USA INC., a Maryland corporation (herein called
the “Company,” which term includes any successor corporation under the Indenture hereinafter referred to), for value received
hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of $[ ] on May 24, 2024 and to pay interest
thereon at a rate per annum equal to 3.750%. The Company will pay interest from May 24, 2022, or from the most recent Interest Payment
Date to which interest has been paid or duly provided for, semi-annually on May 24 and November 24 of each year (beginning on November
24, 2022), until the principal hereof is paid or duly provided for. The interest so payable, and punctually paid or duly provided for,
on any Interest Payment Date will, as provided in the Indenture, be paid to the Holder of this Global Security (or one or more Predecessor
Securities) of record at the close of business on the Regular Record Date for such interest, which shall be the fifteenth calendar day
(whether or not a Business Day) preceding such Interest Payment Date except that interest payable at maturity shall be paid to the same
Person to whom the principal of this Global Security is payable. Interest will be computed on the basis of a 360-day year of twelve 30-day
months. Any such interest not so punctually paid or duly provided for shall forthwith cease to be payable to the Holder on such Regular
Record Date, and may be paid to the Holder of this Global Security (or one or more Predecessor Securities) of record at the close of business
on a Special Record Date fixed by the Trustee for the payment of such defaulted interest, notice whereof shall be given to Holders not
less than 10 days prior to such Special Record Date, or may be paid at any time in any other lawful manner not inconsistent with the requirements
of any securities exchange on which the Notes may be listed, and upon such notice as may be required by such exchange, all as more fully
provided in the Indenture.

 

    	 	 1	 

     

    

 

Payment of the principal of this Global Security
and, unless otherwise paid as hereinafter provided, the interest (if any) hereon will be made at the office or agency of the Paying Agent
in New York, New York or at such other office or agency as designated by the Company, in such coin or currency of the United States of
America as at the time of payment is legal tender for payment of public and private debts; provided, however, that payment of interest
may be made at the option of the Company by check mailed to the Person entitled thereto at the address appearing in the Security Register.
Additional provisions of this Global Security are set forth on the reverse hereof.

 

Unless the certificate of authentication hereon
has been executed by or on behalf of the Trustee, by manual signature, this Global Security shall not be entitled to any benefit under
the Indenture, or be valid or obligatory for any purpose.

 

    	 	 2	 

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Global Security to be duly executed.

 

HSBC USA INC.

 

	ATTEST:		 	By:	 
	Name:	 Michele Chebli	 	Name:	Eddy Okhuijsen
	Title:	Senior Assistant Corporate Secretary  	 	Title:	Executive Vice President and Regional Treasurer, Americas

 

CERTIFICATE OF AUTHENTICATION

 

This is one of the Global Securities of the
series designated herein referred to in the within mentioned Indenture.

 

Dated: May 24, 2022

 

COMPUTERSHARE TRUST COMPANY, N.A

(as successor to Wells Fargo Bank, N.A.) 

as Trustee

 

	By:	 	 
	 	Authorized Signatory	 

 

[Signature Page to Form of Fixed Rate Senior Note due May 24, 2024]

 

    	 	 	 

     

    

 

[Reverse of Note]

 

HSBC USA INC.

3.750% SENIOR NOTES DUE MAY 24, 2024

 

This Global Security is one of a duly authorized
issue of notes of the Company (herein called the “Notes”), issuable in series, unlimited in aggregate principal amount except
as may be otherwise provided in respect of the Notes of a particular series, issued and to be issued under and pursuant to an Indenture
dated as of March 31, 2009 (the “Base Indenture”), duly executed and delivered by the Company to Computershare Trust Company,
N.A. (as successor to Wells Fargo Bank, National Association), as Trustee (the “Trustee”) (the Base Indenture, as supplemented
by the First Supplemental Indenture dated as of March 22, 2012 between the Company and the Trustee, the “Indenture”), and
is one of a series designated as 3.750% Senior Notes due May 24, 2024
(herein called the “3.750% Senior Notes”). Reference is hereby made to the Indenture
for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and
the Holders. The 3.750% Senior Notes are general unsecured obligations of the Company.

 

Interest on the 3.750%
Senior Notes will be payable semi-annually on the 24th day of each May and November commencing November 24, 2022 (each an “Interest
Payment Date”). Interest payable on each Interest Payment Date will include interest accrued from and including May 24, 2022, or
from and including the most recent Interest Payment Date to which interest has been paid or duly provided for to but excluding the next
Interest Payment Date. Interest payable prior to maturity will be payable to the Person in whose name a Registered Security is registered
at the close of business on the fifteenth calendar day (whether or not a Business Day) preceding an Interest Payment Date. The interest
payment at maturity will include interest accrued to but excluding the maturity date and will be payable to the Person to whom principal
is payable. If an Interest Payment Date is not a Business Day, such Interest Payment Date shall be postponed to the next succeeding Business
Day, and no interest will accrue on the amount so payable for the period from and after the originally scheduled Interest Payment Date.
If the maturity date falls on a day that is not a Business Day, payment of principal and interest on the 3.750% Senior Notes will be made
on the next day that is a Business Day as if made on the date such payment was due, and no interest will accrue on the amount so payable
for the period from and after the maturity date. Postponement as described above will not result in a default under the 3.750% Senior
Notes or the Indenture.

 

“Business Day” means any day, other
than a Saturday or Sunday, that is neither a legal holiday nor a day on which banking institutions are authorized or required by law or
regulation to close in the City of New York.

 

The 3.750% Senior Notes are not redeemable prior
to maturity by the Company or at the option of the Holders.

 

The 3.750% Senior Notes are not entitled to any
sinking fund.

 

The provisions of the Indenture regarding defeasance
of the Company’s indebtedness shall apply to the 3.750% Senior Notes.

 

    	 	 	 

     

    

 

If any Event of Default with respect to Notes of
this series shall occur and be continuing, the principal of the 3.750% Senior Notes may be declared due and payable in the manner and
with the effect provided in the Indenture.

 

The Indenture permits, with certain exceptions
as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
under the Indenture at any time by the Company with the consent of the Holders of at least 66 2/3% in aggregate principal amount of the
Notes at the time Outstanding of each series which is affected by such amendment or modification, except that certain amendments specified
in the Indenture may be made without approval of Holders of the Notes. The Indenture also contains provisions permitting (i) the Holders
of 66 2/3% in aggregate principal amount of the Outstanding Notes of any series to waive on behalf of the Holders of such series of Notes
compliance by the Company with certain provisions of the Indenture and (ii) the Holders of a majority in aggregate principal amount of
the Outstanding Notes of any series to waive certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holders of the 3.750% Senior Notes shall be binding upon such Holders and upon all future Holders of the 3.750% Senior Notes and
any Notes issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof whether or not notation of such
consent or waiver is made upon such Notes.

 

No reference herein to the Indenture and no provision
of the 3.750% Senior Notes or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional,
to pay the principal of (and premium, if any) and interest on the 3.750% Senior Notes at the times, place and rate, and in the coin or
currency prescribed in the 3.750% Senior Notes.

 

As provided in the Indenture and subject to certain
limitations therein set forth, transfer of this 3.750% Senior Note is registrable on the Security Register, upon surrender of this 3.750%
Senior Note for registration of transfer at the office or agency of the Company in New York, New York duly endorsed by, or accompanied
by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof
or his attorney duly authorized in writing, and thereupon one or more new 3.750% Senior Notes, of authorized denominations and for a like
aggregate principal amount, will be issued to the designated transferee or transferees.

 

The 3.750% Senior Notes are issuable only as registered
Notes without coupons in denominations of $200,000 or any integral multiple of $1,000 in excess thereof authorized by the Company.

 

No service charge will be made for any such registration
of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable
in connection therewith.

 

The Company, the Trustee and any agent of the Company
or the Trustee may treat the Person in whose name this 3.750% Senior Note is registered as the owner hereof for the purpose of receiving
payment as herein provided and for all other purposes whether or not this 3.750% Senior Note be overdue, and neither the Company, the
Trustee nor any such agent shall be affected by notice to the contrary.

 

    	 	 	 

     

    

 

This 3.750% Senior Note is exchangeable by the
Company only if (x) the Depositary notifies the Company that it is unwilling or unable to continue as Depositary for this Global Security
or if at any time the Depositary ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, and
any other applicable statute or regulation, and a successor depositary has not been appointed by the Company within 90 days or (y) the
Company in its sole discretion determines that this 3.750% Senior Note shall be exchangeable for certificated 3.750% Senior Notes in registered
form; provided, that the certificated 3.750% Senior Notes so issued by the Company in exchange for this permanent Global Security shall
be in denominations of $200,000 and any integral multiple of $1,000 in excess thereof and be of like aggregate principal amount and tenor
as the portion of this permanent Global Security to be exchanged, and provided further that, unless the Company agrees otherwise, Notes
of this series in certificated registered form will be issued in exchange for this permanent Global Security, or any portion hereof, only
if such Notes in certificated registered form were requested by written notice to the Trustee or the Securities Registrar by or on behalf
of a Person who is the beneficial owner of an interest hereof given through the Holder hereof. Except as provided above, owners of beneficial
interests in this permanent Global Security will not be entitled to receive physical delivery of Notes in certificated registered form
and will not be considered the Holders thereof for any purpose under the Indenture.

 

All initially capitalized terms used in this 3.750%
Senior Note which are defined in the Indenture have the meanings assigned to them in the Indenture.

 

    	 	 	 

     

    

 

ASSIGNMENT FORM

 

FOR VALUE RECEIVED, the undersigned hereby sells,
assigns and transfers

 

unto

 

	Name and Address of Assignee

 

	(                                                                    )
	 	Social Security Number or other identifying number of Assignee

 

the within Global Security and all rights thereunder,
hereby irrevocably constituting and appointing                                                                                Attorney to transfer said Global Security on the books of the Company,
with full power of substitution in premises.

 

Dated:                                                                              

 

	 	NOTICE: The Signature to this Assignment must correspond
    with the name written upon the face of this Note in every particular, without alteration or enlargement or any change whatever.EX-4.5

 Exhibit 4.5 

DESCRIPTION OF SECURITIES 
 General

 We are be authorized to issue 50,000,000 shares of common stock, par value $0.0001, and 1,000,000 shares of preferred stock, par value
$0.0001. 22,037,500 shares of common stock are currently outstanding. No shares of preferred stock are currently outstanding. The following description summarizes the material terms of our securities. Because this description is only a summary,
it may not contain all the information that is important to you. For a complete description you should refer to our amended and restated certificate of incorporation, bylaws and warrant agreement, which are filed as exhibits (including by
incorporation) to the Current Report on Form 8-K we filed with the SEC on February 9, 2021 (the “8-K”), the Registration Statement on Form S-1 (SEC File No. 333- 252010) we filed with the SEC on January 26, 2021 (the “Registration Statement”) in connection with our initial public offering (the “IPO”), and to the applicable
provisions of Delaware law. 
 Units 
 Each unit
consists of one share of common stock and one-half of one warrant. The shares of common stock and warrants began to trade separately on March 15, 2021. Holders have the option to continue to hold
units or separate their units into the component pieces. 
 Each whole warrant entitles the holder to purchase one share of common stock. Pursuant to the
warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon
separation of the units and only whole warrants will trade. Accordingly, unless you purchase a multiple of two units, the number of warrants issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants.

 Common Stock 
 Our stockholders of record are
entitled to one vote for each share held on all matters to be voted on by stockholders. Any action required to be taken at any annual or special meeting of stockholders, or any action which may be taken at any annual or special meeting of such
stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes
that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, and shall be delivered to us by delivery to our registered office in the State of Delaware, our principal
place of business, or one of our officers or agents having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to our registered office shall be by hand or by certified or registered mail, return receipt
requested. Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing. 

In connection with any vote held to approve our initial business combination, our sponsor, as well as all of our officers and directors, have agreed to vote
their respective shares of common stock owned by them immediately prior to the IPO and any shares purchased following the IPO in the open market in favor of the proposed business combination. 

We will consummate our initial business combination only if we have net tangible assets of at least $5,000,001 either immediately prior to or upon
consummation of such business combination and, solely if a vote is held to approve a business combination, a majority of the outstanding shares of common stock voted are voted in favor of the business combination. 

Our board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being
elected in each year. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares eligible to vote for the election of directors can elect all of the directors. 

 Pursuant to our amended and restated certificate of incorporation, if we do not consummate an initial
business combination by February 8, 2023, our corporate existence will cease except for the purposes of winding up our affairs and liquidating. If we are forced to liquidate prior to an initial business combination, our public stockholders are
entitled to share ratably in the trust account, based on the amount then held in the trust account. 
 Our sponsor, officers and directors have agreed to
waive their rights to participate in any liquidation distribution from the trust account occurring upon our failure to consummate an initial business combination with respect to the founder’s common stock and shares underlying units purchased
in a private placement concurrent with the IPO or issued in respect of working capital loans to us from our sponsor (the “private shares”). Our sponsor, officers and directors will therefore not participate in any liquidation distribution
from the trust account with respect to such shares. They will, however, participate in any liquidation distribution from the trust account with respect to any shares of common stock acquired in the open market following the IPO. 

Our stockholders have no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to the shares
of common stock, except that public stockholders have the right to sell their shares to us in a tender offer or have their shares of common stock converted to cash equal to their pro rata share of the trust account in connection with the
consummation of our business combination. Public stockholders who sell or convert their stock into their share of the trust account still have the right to exercise the warrants that they received as part of the units. 

Preferred Stock 
 There are no shares of preferred stock
outstanding. Our amended and restated certificate of incorporation authorizes the issuance of 1,000,000 shares of preferred stock with such designation, rights and preferences as may be determined from time to time by our board of directors. No
shares of preferred stock were issued or registered in the IPO. 
 Our board of directors is empowered, without stockholder approval, to issue preferred
stock with dividend, liquidation, conversion, voting or other rights which could adversely affect the voting power or other rights of the holders of common stock. However, our underwriting agreement prohibits us, prior to a business combination,
from issuing preferred stock which participates in any manner in the proceeds of the trust account, or which votes as a class with the common stock on a business combination. We may issue some or all of the preferred stock to effect a business
combination. In addition, the preferred stock could be utilized as a method of discouraging, delaying or preventing a change in control of us. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we
will not do so in the future. 
 Warrants 
 17,725,000
warrants are currently outstanding. Each whole warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the
completion of an initial business combination. However, no warrants will be exercisable for cash unless we have an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current
prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within a specified period following the
consummation of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants
on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act of 1933 as amended (the “Securities Act”), provided that such exemption is available. If that exemption, or another exemption, is not
available, holders will not be able to exercise their warrants on a cashless basis. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the
quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by
(y) the fair market value. The “fair market value” for this purpose will mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the trading day prior to the date of exercise. The
warrants will expire on the fifth anniversary of our completion of an initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. 

The private warrants, as well as any warrants underlying additional units we issue to our sponsor, officers, directors or their affiliates in payment of
working capital loans made to us, will be identical to the warrants underlying the units being offered by this prospectus except that such warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and will not be
redeemable by us, in each case so long as they are still held by our sponsor or its permitted transferees. 

 We may call the warrants for redemption (excluding the private warrants and any warrants underlying
additional units issued to our sponsor, initial stockholders, officers, directors or their affiliates in payment of working capital loans made to us), in whole and not in part, at a price of $0.01 per warrant, 

 

	 	•	 	 at any time after the warrants become exercisable, 

 

	 	•	 	 upon not less than 30 days’ prior written notice of redemption to each warrant holder,

  

	 	•	 	 if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share
(as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to
the notice of redemption to warrant holders; and 

  

	 	•	 	 if, and only if, there is a current registration statement in effect with respect to the shares of common stock
underlying such warrants. 

 The right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the
notice of redemption. On and after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder’s warrant upon surrender of such warrant. 

The redemption criteria for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial
exercise price and provide a sufficient differential between the then-prevailing share price and the warrant exercise price so that if the share price declines as a result of our redemption call, the redemption will not cause the share price to
drop below the exercise price of the warrants. 
 If we call the warrants for redemption as described above, our management will have the option to require
all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by
dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market
value. The “fair market value” for this purpose shall mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the third trading day prior to the date on which the notice of redemption is
sent to the holders of warrants. 
 The warrants have been issued in registered form under a warrant agreement between Continental Stock Transfer &
Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval, by written
consent or vote, of the holders of at least a majority of the then outstanding public warrants in order to make any change that adversely affects the interests of the registered holders. 

The exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event
of a stock dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of shares of common stock at a price below their
respective exercise prices. 
 In addition, if (x) we issue additional shares of common stock or equity-linked securities for capital raising
purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by our
board of directors, and in the case of any such issuance to our sponsor, initial stockholders or their affiliates, without taking into account any founders’ shares held by them prior to such issuance), (y) the aggregate gross proceeds from
such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and
(z) the Market Value is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which we issue the additional
shares of common stock or equity-linked securities. 

 The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date
at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price, by certified or official bank check payable to us, for
the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of shares of common stock and any voting rights until they exercise their warrants and receive shares of common stock. After the issuance of
shares of common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders. 

Warrant holders may elect to be subject to a restriction on the exercise of their warrants such that an electing warrant holder would not be able to exercise
their warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess of 9.8% of the shares of common stock outstanding. 

No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional
interest in a share, we will, upon exercise, round up to the nearest whole number the number of shares of common stock to be issued to the warrant holder. 

Dividends 
 We have not paid any cash dividends on our
shares of common stock to date and do not intend to pay cash dividends prior to the completion of a business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and
general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to a business combination will be within the discretion of our then board of directors. It is the present intention of our board
of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board does not anticipate declaring any dividends in the foreseeable future. 

Our Transfer Agent and Warrant Agent 
 The transfer agent
for our securities and warrant agent for our warrants is Continental Stock Transfer & Trust Company, 1 State Street, New York, New York 10004. 

Listing of our Securities 
 Our units, common stock and
warrants are listed on Nasdaq under the symbols “ASAXU,” “ASAX,” and “ASAXW,” respectively. The common stock and warrants are eligible to trade separately. 

Certain Anti-Takeover Provisions of Delaware Law and our Amended and Restated Certificate of Incorporation and
By-Laws 
 Staggered board of directors 

Our amended and restated certificate of incorporation provides that our board of directors will be classified into three classes of directors of approximately
equal size. As a result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual meetings. 

Special meeting of stockholders 
 Our bylaws
provide that special meetings of our stockholders may be called only by a majority vote of our board of directors, by our president or by our chairman or by our secretary at the request in writing of stockholders owning a majority of our issued and
outstanding capital stock entitled to vote. 
 Advance notice requirements for stockholder proposals and director nominations 

Our bylaws provide that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors
at our annual meeting of stockholders must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be delivered to our principal executive offices not later than the close of business on the 60th day nor earlier than the close of business on the 90th day prior to the scheduled date of the annual meeting of stockholders. In the
event that less than 70 days’ notice or prior public disclosure of the 

 
date of the annual meeting of stockholders is given, a stockholder’s notice shall be timely if delivered to our principal executive offices not later than the 10th day following the day on which public announcement of the date of our annual meeting of stockholders is first made or sent by us. Our bylaws also specify certain requirements as to the form and
content of a stockholders’ meeting. These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders. 

Authorized but unissued shares 
 Our authorized but
unissued common stock and preferred stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee
benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. 

Exclusive Forum Selection 
 Our amended and
restated certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions against directors, officers and employees for breach of fiduciary duty and other similar actions may be
brought only in the Court of Chancery in the State of Delaware, except any action (A) as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of
Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the
Court of Chancery, (C) for which the Court of Chancery does not have subject matter jurisdiction or (D) arising under the Securities Act. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have
consented to service of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may
determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against our directors and officers, although our stockholders will not be deemed to have waived our
compliance with federal securities laws and the rules and regulations thereunder and therefore bring a claim in another appropriate forum. Additionally, we cannot be certain that a court will decide that this provision is either applicable or
enforceable, and if a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such
action in other jurisdictions, which could harm our business, operating results and financial condition. 
 Our amended and restated certificate of
incorporation provides that the exclusive forum provision is applicable to the fullest extent permitted by applicable law. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or
liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the
federal courts have exclusive jurisdiction.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]